UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

SCHEDULE 13G

(Under the Securities Exchange Act of 1934)

(Amendment No.3)*

Uroplasty Inc.
(Name of Issuer)

Common Stock
(Title of Class of Securities)

917277204
(Cusip Number)

December 31, 2009
(Date of event which requires filing of this statement)

Check the appropriate box to designate the rule pursuant
to which this schedule is filed:

[X] Rule 13d-1 (b)Babson Capital Management LLC
[X] Rule 13d-1 (c)Cobbs Wharf Master Fund, L.P.
[ ] Rule 13d-1 (d)

*The remainder of this cover page shall be filled out for a reporting person's initial filing of this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes.)

[Continued on the following page(s)]

Page 1 of 8 Pages

CUSIP No 917277204 Page 2 of 8 Pages
----------------------------------------------------------------
1. Name of reporting person
 S.S. or I.R.S. identification no. of above person

 Babson Capital Management LLC
 51-0504477
----------------------------------------------------------------
2. Check the appropriate box if a member of a group
 (a)( )
 (b)( X )
----------------------------------------------------------------
3. SEC use only
----------------------------------------------------------------
4. Citizenship or place of organization
 Delaware
----------------------------------------------------------------
 5. Sole Voting Power

 0
 Number of -----------------------------
 shares 6. Shared Voting Power
 beneficially
 owned by 0
 each -----------------------------
 Reporting 7. Sole Dispositive Power
 person
 with 0
 -----------------------------
8. Shared Dispositive Power
 0
 ---------------------------------------------------------------
9. Aggregate amount beneficially owned by each reporting person

 0
 ---------------------------------------------------------------
10. Check if the aggregate amount in row (9) excludes certain shares*

 ----------------------------------------------------------------
11. Percent of class represented by amount in row 9
 0%
 ----------------------------------------------------------------
12. Type of Reporting person
 IA







CUSIP No 917277204 Page 2 of 8 Pages
----------------------------------------------------------------
1. Name of reporting person
 S.S. or I.R.S. identification no. of above person

 Cobbs Wharf Master Fund, L.P.
----------------------------------------------------------------
2. Check the appropriate box if a member of a group
 (a)( )
 (b)( X )
----------------------------------------------------------------
3. SEC use only
----------------------------------------------------------------
4. Citizenship or place of organization
 Delaware
----------------------------------------------------------------
 5. Sole Voting Power

 0
 Number of -----------------------------
 shares 6. Shared Voting Power
 beneficially
 owned by 0
 each -----------------------------
 Reporting 7. Sole Dispositive Power
 person
 with 0
 -----------------------------
8. Shared Dispositive Power
 0
 ---------------------------------------------------------------
9. Aggregate amount beneficially owned by each reporting person

 0
 ---------------------------------------------------------------
10. Check if the aggregate amount in row (9) excludes certain shares*

 ----------------------------------------------------------------
11. Percent of class represented by amount in row 9
 0%
 ----------------------------------------------------------------
12. Type of Reporting person
 PN




CUSIP No 917277204 Page 4 of 8 Pages
----------------------------------------------------------------

SCHEDULE 13G

ITEM 1(A): NAME OF ISSUER:

 Uroplasty, Inc.


1(B): ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:

 5420 FELTL ROAD
 MINNETONKA MN 55343


ITEM 2(A): NAME OF PERSON FILING:
(i) Babson Capital Management LLC (Babson) as investment adviser.
(ii) Cobbs Wharf Master Fund, L.P. (Cobbs Wharf)

ITEM 2(B): ADDRESS OF PRINCIPAL BUSINESS OFFICE:

Babson Capital Management LLC
470 Atlantic Avenue
Boston, MA 02210-2208

Cobbs Wharf Master Fund, L.P.
470 Atlantic Avenue
Boston, MA 02210-2208


ITEM 2(C): CITIZENSHIP:

 See Cover Page

ITEM 2(D): TITLE OF CLASS OF SECURITIES:

 See Cover Page

ITEM 2(E): CUSIP NUMBER:

 See Cover Page

ITEM 3: TYPE OF REPORTING PERSON:

If this statement is filed pursuant to Sections 240.13d-1 (b)
or 240.13d-2 (b) or (c), check whether the filing person is a:
(e) [x] An investment adviser in accordance with
 Section 240.13d-1 (b) (1) (ii) (E)

ITEM 4: OWNERSHIP:
(a)AMOUNT BENEFICIALLY OWNED: Babson Capital Management LLC
(Babson Capital) in its capacity as investment adviser, is no longer
the beneficial owner of shares of common stock of the Issuer
which were previously owned by investment advisory client(s).

Cobbs Wharf Master Fund, L.P. no longer beneficially owns shares.
Cobbs Wharf Master Fund, L.P., a Cayman Islands limited Partnership
to which Babson Capital served as investment adviser, was liquidated
and has ceased operations and the shares of Uroplasty, Inc. previously
reported in the Schedule 13G amendment(2), were sold as part of the
Fund's liquidation.





CUSIP No 595125105 Page 5 of 8 Pages
----------------------------------------------------------------


ITEM 5: OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:

If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial
owner of more than five per cent of the class of securities check
the following: [x]


ITEM 6: OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:

 Not Applicable

ITEM 7: IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH
 ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING
 COMPANY:


 Not Applicable

ITEM 8: IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:

 Not Applicable


ITEM 9: NOTICE OF DISSOLUTION OF GROUP:

 Not Applicable

ITEM 10: CERTIFICATION:
BABSON CAPITAL MANAGEMENT LLC CERTIFICATION
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the
ordinary course of business and were not acquired for the purpose of
and do not have the effect of changing or influencing the control of
the issuer of such securities and were not acquired in connection
with or as a participant in any transaction having such purpose or
effect.

SIGNATURE:

After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement
is true, complete and correct.

 Date: February 12, 2010


 Babson Capital Management LLC
 By: // Melissa Lagrant //
 Name: Melissa Lagrant
 Title: Managing Director





CUSIP No 595125105 Page 6 of 8 Pages
----------------------------------------------------------------
COBBS WHARF MASTER FUND, L.P. CERTIFICATION
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired and held
in the ordinary course of business and were not acquired for the
purpose of and do not have the effect of changing or influencing
control of the issuer of such securities and were not acquired in
connection with or as a participant in any transaction having such
purpose or effect.

SIGNATURE:

After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement
is true, complete and correct.

 Date: February 12, 2010

 Cobbs Wharf Master Fund, L.P.
 By: Cobbs Wharf Management, LLC
 Its General Partner

 By: // Melissa Lagrant //
 Name: Melissa Lagrant
 Title: Managing Director




CUSIP No 595125105 Page 7 of 8 Pages
----------------------------------------------------------------
JOINT FILING AGREEMENT

This will confirm the agreement by and among all the undersigned
that the amended Schedule 13G filed on or about this date and any
future amendments thereto with respect to the beneficial ownership
by the undersigned of common shares of Uroplasty, Inc. is being
filed on behalf of each of the undersigned in accordance with
Rule 13d-1(k)(1). This agreement may be executed in two or more
counterparts, each of which shall be deemed an original, but all
of which together shall constitute one and the same instrument.



 Date: February 12, 2010



 Babson Capital Management LLC
 _____________________________
 By: // Melissa Lagrant //
 Name: Melissa Lagrant
 Title: Managing Director




 Date: February 12, 2010


 Cobbs Wharf Master Fund, L.P.
 _____________________________
 By: Cobbs Wharf Management, LLC
 Its General Partner

 By: // Melissa Lagrant //
 Name: Melissa Lagrant
 Title: Managing Director





CUSIP No 595125105 Page 8 of 8 Pages
----------------------------------------------------------------


February 12, 2010


Securities and Exchange Commission
Operations Center
Attn: Stop 0-7
6432 General Green Way
Alexandria, VA 22312-2413



Re: SCHEDULE 13G ON BEHALF OF UROPLASTY INC FOR THE YEAR
 ENDING DECEMBER 31, 2009


Dear Sir or Madam:

Babson Capital Management LLC and Cobbs Wharf Master Fund, L.P.
are filing today an amended Schedule 13G through the EDGAR system
as required by Section 240.13d-1(b) to reflect a change in beneficial
ownership of the outstanding stock of the above-mentioned issuer.

Please note that the shares as to which this Schedule is filed were
owned by various investment advisory clients of Babson Capital.
Babson Capital may have been deemed to be a beneficial owner of the
shares only by virtue of the direct or indirect investment discretion
it possessed pursuant to the provisions of investment advisory agreements
with such clients.

A copy of the Schedule 13G is being sent to the issuer as required by
Rule 13d-7.

Comments or questions concerning the above may be directed to the
undersigned at (617) 761-3731.

Sincerely,



// Melissa Lagrant //
Melissa Lagrant
Mananging Director

Uroplasty (AMEX:UPI)
過去 株価チャート
から 5 2024 まで 5 2024 Uroplastyのチャートをもっと見るにはこちらをクリック
Uroplasty (AMEX:UPI)
過去 株価チャート
から 5 2023 まで 5 2024 Uroplastyのチャートをもっと見るにはこちらをクリック